Pfizer’s vice president and Head of Early Clinical Development
SMi Group’s next annual Adaptive Designs in Clinical Trials conference is thrilled to welcome Sandeep Menon, Vice President and Head of Early Clinical Development at Pfizer Inc. onto the speaker panel for 2019.
He is currently leading a multi- functional global team which includes Biostatisticians, Clinical Pharmacologists, Clinicians, Precision Medicine Scientists and Digital Medicine Scientists. Sandeep has extensive experience in late phase studies and with regulatory interactions especially with the FDA (US Agency), EMA (European Agency) and PMDA (Japan Agency). He is internationally known for his technical expertise especially in the area of adaptive designs, personalized medicine, multi-regional trials, and small populations and has participated in the core review of draft version of the regulatory guidance documents.
A key topic focus in Sandeep’s presentation is statistical and design considerations in personalised medicine. He will be discussing Identifying genetic, genomic and clinical characteristics to predict patient susceptibility. Biomarkers and the challenges in their use for diagnostics and looking into selecting appropriate designs to determine biomarker performance, reliability and regulatory acceptance.
Additionally, the vice president will explore case studies for biomarker driven trials.
For those looking to attend there is currently a £200 early-bird saving.
Further information is available at: www.adaptivedesigns.co.uk/pharmapr2
SMi Presents the 11th Annual Conference on…
Adaptive Designs in Clinical Trials
Date: 1-2 April 2019
Location: London, UK
For all media inquiries contact Jinna Sidhu on Tel: +44 (0)20 7827 6088 / Email: firstname.lastname@example.org
About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk